GCVCX
Price
$24.15
Change
+$0.22 (+0.92%)
Updated
Aug 13 closing price
Net Assets
534.62M
RMFCX
Price
$60.24
Change
+$0.18 (+0.30%)
Updated
Aug 13 closing price
Net Assets
109.66B
Interact to see
Advertisement

GCVCX vs RMFCX

Header iconGCVCX vs RMFCX Comparison
Open Charts GCVCX vs RMFCXBanner chart's image
Goldman Sachs Large Cp Val Insghts C
Price$24.15
Change+$0.22 (+0.92%)
VolumeN/A
Net Assets534.62M
American Funds American Mutual R3
Price$60.24
Change+$0.18 (+0.30%)
VolumeN/A
Net Assets109.66B
GCVCX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCVCX vs. RMFCX commentary
Aug 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCVCX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 110B vs. GCVCX (535M). RMFCX pays higher dividends than GCVCX: RMFCX (1.26) vs GCVCX (0.23). GCVCX was incepted earlier than RMFCX: GCVCX (27 years) vs RMFCX (23 years). GCVCX (1.77) is less costly to investors than RMFCX (0.91). GCVCX is a more actively managed with annual turnover of: 206.00 vs. RMFCX (31.00). RMFCX has a lower initial minimum investment than GCVCX: RMFCX (250) vs GCVCX (1000). RMFCX annual gain was more profitable for investors over the last year : 9.63 vs. GCVCX (-3.22). RMFCX return over 5 years is better than : 55.38 vs. GCVCX (22.19).
GCVCXRMFCXGCVCX / RMFCX
Total Expense Ratio1.670.91184%
Annual Report Gross Expense Ratio1.770.91195%
Fund Existence27 years23 years-
Gain YTD4.69011.03443%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets535M110B0%
Annual Yield % from dividends0.231.2619%
Returns for 1 year-3.229.63-33%
Returns for 3 years7.8423.7833%
Returns for 5 years22.1955.3840%
Returns for 10 years45.2079.8757%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.280.07
+5.79%
Pacific Biosciences of California
EMCG13.670.33
+2.47%
Embrace Change Acquisition Corp
BCRX8.530.18
+2.16%
BioCryst Pharmaceuticals
MTSI125.990.54
+0.43%
MACOM Technology Solutions Holdings
PCTTU17.80N/A
N/A
PureCycle Technologies